Knockdown of AKAP13 and AKAP95 does not impair MCF-7 cell proliferation in vehicle, E2, tamoxifen and Fulvestrant (ICI) treated cells. Cells were seeded in 48 well format, and transfected with siCntrl, siAKAP13 or siAKAP95. After 1Â week, cells were processed for crystal violet cell quantifications. (PDF 219Â kb
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. GPER stimulation triggers FAK Y397 activation in SUM159 TNBC cells. Immunoblots showing F...
siRNA targeting AKAP95 does not influence PKA-induced ERαS305 phosphorylation. MCF-7 breast cancer c...
AKAP95 expression does not correlate with progression-free survival (A) and 305P status (B). (PDF 40...
Univariate analysis for different AKAP13Â probes. Table S2. Univariate analysis. Table S3. Multivari...
Additional file 1: Supplementary Figure 1. a. The protein expression levels of STAT5 and p-STAT5 wer...
Figure S1. Tamoxifen-resistant cell lines display distinct expression changes. Tamoxifen-resistant c...
Figure. S1. a Expression level of AFF3 and SLC116A14 in breast cancer tissues compared with noncance...
Figure S1. SNAI2 and E-cadherin protein levels following siRNA-mediated SNAI2 knockdown. MCF-7-based...
Figure. S2. a Colony formation assay of MCF-7 and T47D cells, derived AFF3 knock down clones seeded ...
Effects of AKT and MAPK inhibition on apoptosis in BT474 and MDAMB361 cells. Cell lines grown in 2D ...
Unsupervised clustering of microarray analysis. 1 represented for MCF-7, and 2 represented for MCF-7...
PCA of microarray analysis. 1 represented for MCF-7, and 2 represented for MCF-7/ADR. (PNG 146Â kb
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. GPER stimulation triggers FAK Y397 activation in SUM159 TNBC cells. Immunoblots showing F...
siRNA targeting AKAP95 does not influence PKA-induced ERαS305 phosphorylation. MCF-7 breast cancer c...
AKAP95 expression does not correlate with progression-free survival (A) and 305P status (B). (PDF 40...
Univariate analysis for different AKAP13Â probes. Table S2. Univariate analysis. Table S3. Multivari...
Additional file 1: Supplementary Figure 1. a. The protein expression levels of STAT5 and p-STAT5 wer...
Figure S1. Tamoxifen-resistant cell lines display distinct expression changes. Tamoxifen-resistant c...
Figure. S1. a Expression level of AFF3 and SLC116A14 in breast cancer tissues compared with noncance...
Figure S1. SNAI2 and E-cadherin protein levels following siRNA-mediated SNAI2 knockdown. MCF-7-based...
Figure. S2. a Colony formation assay of MCF-7 and T47D cells, derived AFF3 knock down clones seeded ...
Effects of AKT and MAPK inhibition on apoptosis in BT474 and MDAMB361 cells. Cell lines grown in 2D ...
Unsupervised clustering of microarray analysis. 1 represented for MCF-7, and 2 represented for MCF-7...
PCA of microarray analysis. 1 represented for MCF-7, and 2 represented for MCF-7/ADR. (PNG 146Â kb
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. GPER stimulation triggers FAK Y397 activation in SUM159 TNBC cells. Immunoblots showing F...